Asset Management One’s Avadel Pharmaceuticals AVDL Stock Holding History

Asset Management One’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-245,862	Closed	-$2.96M	–	1017
2016 Q3	$2.96M	Sell	245,862 -5,856	-2%	-$76.5K	0.04%	478
2016 Q2	$2.72M	Sell	251,718 -44,801	-15%	-$478K	0.04%	502
2016 Q1	$3.21M	Buy	296,519 +97	+0%	+$963	0.05%	457
2015 Q4	$4.35M	Sell	296,422 -43,578	-13%	-$679K	0.06%	352
2015 Q3	$5.22M	Buy	340,000 +18,717	+6%	+$412K	0.08%	308
2015 Q2	$6.68M	Buy	321,283 +31,911	+11%	+$572K	0.09%	290
2015 Q1	$5.21M	Buy	+289,372	New	+$4.53M	0.06%	379

Other funds holding AVDL

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

FPC

Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return

Asset Management One's AVDL Position: Q4 2016 in Review

Asset Management One sold out of Avadel Pharmaceuticals (AVDL) in Q4 2016, closing a stake of 245,862 shares — an estimated $2.96M sold.

Asset Management One first reported a position in AVDL in Q1 2015 and held it in 7 quarters. The position peaked at $6.68M in Q2 2015. 76 funds tracked by Wall St. Rank hold AVDL as of Q4 2016.

Asset Management One reported no remaining Avadel Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Asset Management One sold 245,862 Avadel Pharmaceuticals shares in Q4 2016, an estimated $2.96M.
Asset Management One first reported a position in Avadel Pharmaceuticals in Q1 2015 and held it in 7 quarters.
Asset Management One's Avadel Pharmaceuticals position peaked at $6.68M in Q2 2015.
76 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2016.

Based on Asset Management One's 13F filing for Q4 2016, filed 13 Feb 2017.